Alerts will be sent to your verified email
Verify EmailHEMORGANIC
|
Hemo Organic
|
Ganga Pharma.
|
Secunderabad Health.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-361.35 % | 0.71 % | n/a |
|
5yr average Equity Multiplier
|
-1.56 | 1.37 | n/a |
|
5yr Average Asset Turnover Ratio
|
0.14 | 0.31 | n/a |
|
5yr Avg Net Profit Margin
|
-763.22 % | 1.72 % | n/a |
|
Price to Book
|
0.0 | 0.98 | n/a |
|
P/E
|
50.0 | 87.37 | n/a |
|
5yr Avg Cash Conversion Cycle
|
100.48 Days | 237.0 Days | n/a |
|
Inventory Days
|
406.93 Days | 165.67 Days | n/a |
|
Days Receivable
|
196.55 Days | 126.89 Days | n/a |
|
Days Payable
|
2776.86 Days | 119.78 Days | n/a |
|
5yr Average Interest Coverage Ratio
|
-250.54 | 1.32 | n/a |
|
5yr Avg ROCE
|
37.52 % | 3.77 % | n/a |
|
5yr Avg Operating Profit Margin
|
-745.72 % | 0.19 % | n/a |
|
5 yr average Debt to Equity
|
-0.73 | 0.28 | n/a |
|
5yr CAGR Net Profit
|
n/a | 31.95 % | n/a |
|
5yr Average Return on Assets
|
-33.34 % | 0.53 % | n/a |
|
Shareholdings
|
|||
|
Promoter Holding
|
16.85 % | 50.91 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -15.8 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Hemo Organic
|
Ganga Pharma.
|
Secunderabad Health.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|